Search

everythinglearnresearchcommunity

for

Search:↓

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Upadacitinib may effectively treat resistant lichen planopilaris.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Clofazimine effectively treated ashy dermatosis in a patient.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

A patient with complete hair loss regrew all her hair using tofacitinib.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.